Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Developmental programs in neuroblastoma

ABSTRACT: Developmental programs in neuroblastoma

PROVIDER: PRJNA686093 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13268234_1.fastq.gz	Fastqsanger.gz
	SRR13268234_2.fastq.gz	Fastqsanger.gz
	SRR13268235_1.fastq.gz	Fastqsanger.gz
	SRR13268235_2.fastq.gz	Fastqsanger.gz
	SRR13268236_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Developmental programs in neuroblastoma [scRNA-seq IMR575-shMYCN]

Project description:Developmental programs in neuroblastoma [scRNA-seq IMR575-shMYCN]

| PRJNA686096 | ENA

Developmental programs in childhood neuroblastoma [scRNA-seq SK-N-AS]

Project description:Developmental programs in childhood neuroblastoma [scRNA-seq SK-N-AS]

| PRJNA686095 | ENA

Developmental programs in neuroblastoma [scRNA-seq IMR575-shMYCN]

Project description:Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. We investigate developmental origins of neuroblastoma, the role of oncogenic MYCN in blocking normal differentiation and evaluate therapeutic interventions to overcome differentiation blocks. Here, we provide single cell expression profiles of IMR5/75-shMYCN cells upon knockdown of MYCN and control.

2020-12-18 | GSE163429 | GEO

Developmental programs in neuroblastoma [RNA-seq SK-N-BE(2)C ATRA]

Project description:Developmental programs in neuroblastoma [RNA-seq SK-N-BE(2)C ATRA]

| PRJNA686094 | ENA

Developmental programs in childhood neuroblastoma [scRNA-seq SK-N-AS]

Project description:Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. We investigate the developmental origin of neuroblastoma, the role of oncogenic MYCN in blocking normal differentiation and evaluate therapeutic interventions to overcome differentiation blocks. Here, we provide single cell expression profiles (scRNA-seq MARS-seq) of SK-N-AS cells (n=603).

2020-12-18 | GSE163430 | GEO

Developmental programs in neuroblastoma [RNA-seq SK-N-BE(2)C ATRA]

Project description:Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. We investigate developmental origins of neuroblastoma, the role of oncogenic MYCN in blocking normal differentiation and evaluate therapeutic interventions to overcome differentiation blocks. Here, we provide expression profiles of SK-N-BE(2)C cells upon treatment with ATRA or solvent control.

2020-12-18 | GSE163428 | GEO

Fetal specific human B-cell developmental programs

Project description:Fetal specific human B-cell developmental programs

| PRJNA507185 | ENA

VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis

Project description:VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis

| PRJNA848822 | ENA

Developmental chromatin programs determine oncogenic competence in melanoma

Project description:Developmental chromatin programs determine oncogenic competence in melanoma

| PRJNA721948 | ENA

Predicting Neuroblastoma Using Developmental Signals and a Logic-Based Model

Project description:Genomic information from human patient samples of pediatric neuroblastoma cancers and known outcomes have led to specific gene lists put forward as high risk for disease progression. However, the reliance on gene expression correlations rather than mechanistic insight has shown limited potential and suggests a critical need for molecular network models that better predict neuroblastoma progression. In this study, we construct and simulate a molecular network of developmental genes and downstream signals in a 6-gene input logic model that predicts a favorable/unfavorable outcome based on the outcome of the four cell states including cell differentiation, proliferation, apoptosis, and angiogenesis. We simulate the mis-expression of the tyrosine receptor kinases, trkA and trkB, two prognostic indicators of neuroblastoma, and find differences in the number and probability distribution of steady state outcomes. We validate the mechanistic model assumptions using RNAseq of the SHSY5Y human neuroblastoma cell line to define the input states and confirm the predicted outcome with antibody staining. Lastly, we apply input gene signatures from 77 published human patient samples and show that our model makes more accurate disease outcome predictions for early stage disease than any current neuroblastoma gene list. These findings highlight the predictive strength of a logic-based model based on developmental genes and offer a better understanding of the molecular network interactions during neuroblastoma disease progression.

2018-05-31 | GSE115166 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data